🇺🇸 Prilocaine 0.66% in United States

FDA authorised Prilocaine 0.66% on 18 November 1965

Marketing authorisation

FDA — authorised 18 November 1965

  • Application: NDA014763
  • Marketing authorisation holder: ASTRAZENECA
  • Local brand name: CITANEST
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

Other Anesthesia approved in United States

Frequently asked questions

Is Prilocaine 0.66% approved in United States?

Yes. FDA authorised it on 18 November 1965.

Who is the marketing authorisation holder for Prilocaine 0.66% in United States?

ASTRAZENECA holds the US marketing authorisation.